Literature DB >> 22927089

Phenolic diterpenes from rosemary suppress cAMP responsiveness of gluconeogenic gene promoters.

Young Sook Yun1, Sachie Noda, Genta Shigemori, Ryunosuke Kuriyama, Shigeru Takahashi, Mariko Umemura, Yuji Takahashi, Hideshi Inoue.   

Abstract

The cAMP/protein kinase A/cAMP response element (CRE)-binding protein pathway is important for various physiological aspects including regulation of gluconeogenic gene expression. Rosemary, a well-known herb, has been reported to decrease blood glucose levels. We found that methanol extracts of rosemary suppressed forskolin (FSK)-stimulated luciferase expression under the control of CRE, as well as the promoters for cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) and glucose-6-phosphatase (G6Pase) catalytic subunit genes in human hepatoma HepG2 cells. Three abietane-type diterpenes and two flavonoids were isolated from the rosemary extracts. Among these, 7-O-methylrosmanol (1) and royleanonic acid (3) effectively suppressed FSK-induced luciferase expression under the control of the CRE, PEPCK-C and G6Pase gene promoters. PEPCK-C and G6Pase, which play a key role in the homeostatic regulation of blood glucose levels, are important for managing type II diabetes mellitus. Therefore, the ability of rosemary and its components to suppress cAMP responsiveness of the PEPCK-C or G6Pase gene may contribute to its antihyperglycemic activity.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22927089     DOI: 10.1002/ptr.4794

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  3 in total

Review 1.  Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review.

Authors:  Faezeh Vahdati Hassani; Kobra Shirani; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-13       Impact factor: 3.000

2.  Immunomodulatory effects of preparations from Anthroposophical Medicine for parenteral use.

Authors:  Carsten Gründemann; Christoph Diegel; Barbara Sauer; Manuel Garcia-Käufer; Roman Huber
Journal:  BMC Complement Altern Med       Date:  2015-07-09       Impact factor: 3.659

Review 3.  Rosemary Extract as a Potential Anti-Hyperglycemic Agent: Current Evidence and Future Perspectives.

Authors:  Madina Naimi; Filip Vlavcheski; Hesham Shamshoum; Evangelia Tsiani
Journal:  Nutrients       Date:  2017-09-01       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.